最近，龙大美食的烦恼可能有点多。 该公司发布的业绩预告显示，2025年预计亏损6.2亿元至7.6亿元，相比上年同期176.35万元的亏损额，显著拉大。 盈利承压背后，该公司此前4年的财务数据也被追溯。 发布业绩预告的当日，龙大美食公告称，公司因2021年至2024年连续四年可转债募投项目利息资本化违规被责令改正，相关责任人也收到警示函。龙大美 食也对前期会计差错进行了追溯调整，同一日内相继发布了更正后的2021年至2024年的4年年报。 高达6.2亿元至7.6亿元的业绩预亏，以及对过去4年财报的修正，使龙大美食成为投资者关注的焦点。 | 项目 | 本报告期 | 上年同期 | | --- | --- | --- | | 归属于上市公司 股东的净利润 | 亏损:62.000 万元-76.000 万元 | 亏损:176.35 万元 | | 扣除非经常性损 益后的净利润 | 亏损:62,062 万元-76,062 万元 | 亏损:8,158.66 万元 | | 基本每股收益 | 亏损:0.57 元/股-0.7 元/股 | 亏损:0.0016 元/股 | △龙大美食2025年业绩预告 回溯龙大美食近几年的经营轨迹，则会 ...

Core Viewpoint - The announcement of a suspension of trading by Gaole Co., Ltd. (002348.SZ) due to the potential transfer of shares or voting rights by its largest shareholder, Huadong Group, has attracted significant attention in the capital market, indicating a possible change in control of the company [1] Group 1: Shareholder Changes - Huadong Group is planning to transfer its shares or delegate voting rights, which may lead to a change in control of Gaole Co., Ltd. The stock will be suspended from trading starting November 25, with an expected suspension period of no more than two trading days [1] - Following the announcement, Gaole Co., Ltd.'s stock price closed at 4.81 yuan, reaching the daily limit with a 10.07% increase, and a trading volume of 26.79 million shares, indicating significant market activity prior to the announcement [1] - Huadong Group, which took control of Gaole Co., Ltd. three years ago, may be completely divesting from this cross-industry investment [1] Group 2: Historical Context - In November 2022, Huadong Group acquired 133 million shares (14% of total equity) from Hong Kong Xingchang for 290 million yuan, along with voting rights for an additional 73.31 million shares (7.74% of total equity), achieving a total control of 21.74% of voting rights [2] - The initial goal of Huadong Group was to stabilize Gaole Co., Ltd.'s toy business and facilitate its industrial transformation, including a proposed 2 billion yuan solid-state battery project [2] - The merger faced challenges due to the significant differences in industry focus, with Huadong Group primarily engaged in pig farming and slaughtering, while Gaole Co., Ltd. specializes in toy manufacturing [2] Group 3: Financial Performance - Gaole Co., Ltd. reported a revenue of 226 million yuan for the third quarter of 2025, a year-on-year increase of 10.06%, but still recorded a net loss of 11.67 million yuan, although this represented a 65.91% reduction in losses compared to the previous year [3] - The company achieved a significant net profit of 16.28 million yuan in the third quarter, a year-on-year increase of 936.40%, primarily driven by non-recurring gains [3] - Huadong Group's performance has also been under pressure, with a net loss of 5.16 million yuan in the third quarter of 2025, influenced by a downturn in the pig farming industry [3] Group 4: Market Speculation - The market is particularly interested in the identity of the potential buyer and the transfer price, as the announcement did not disclose specific details about the transaction [4] - The ownership structure of Gaole Co., Ltd. has become more fragmented, with previous transactions in 2022 involving shareholders Chen Zhu and Wang Xiangyu acquiring 5.46% and 5.54% of shares, respectively, adding uncertainty to the control change [4]

Core Viewpoint - The announcement of a potential change in control at Gaole Co., Ltd. has attracted significant attention in the capital market, with the first major shareholder, Huadong Group, planning to transfer its shares or delegate voting rights, leading to a stock suspension starting November 25, expected to last no more than two trading days [1] Group 1: Shareholder Changes - Huadong Group is considering transferring its shares or delegating voting rights, which may result in a change of control at Gaole Co., Ltd. [1] - The stock price of Gaole Co., Ltd. closed at 4.81 yuan, with a daily increase of 10.07% and a trading volume of 1.26 billion yuan, indicating significant market activity prior to the announcement [1] - The market is keenly awaiting details of the transaction, as the Huadong Group, controlled by the Zhu brothers, may completely divest from Gaole Co., Ltd. after three years of ownership [1] Group 2: Historical Context - In November 2022, Huadong Group acquired a 21.74% voting control in Gaole Co., Ltd. through a combination of share transfer and voting rights delegation, becoming the controlling shareholder [2] - The initial goal of Huadong Group was to stabilize Gaole Co., Ltd.'s toy business and facilitate its industrial transformation, including a proposed 2 billion yuan solid-state battery project [2] - The merger faced challenges due to the significant industry differences between Huadong Group's core business in pig farming and Gaole Co., Ltd.'s focus on toy manufacturing [2] Group 3: Financial Performance - Gaole Co., Ltd. reported a revenue of 226 million yuan for the third quarter of 2025, a year-on-year increase of 10.06%, but still recorded a net loss of 11.67 million yuan, although this was a 65.91% reduction in losses compared to the previous year [3] - The company achieved a significant net profit of 16.28 million yuan in the third quarter, a year-on-year increase of 936.40%, primarily due to non-recurring gains [3] - Huadong Group's performance has also been under pressure, with a net loss of 5.16 million yuan in the third quarter of 2025, influenced by a downturn in the pig farming industry [3] Group 4: Market Speculation - The market is particularly interested in the identity of the potential buyer and the transfer price, as the announcement did not disclose specific details about the transaction [4] - The previous year saw a more dispersed shareholding structure, which adds uncertainty to the potential change in control [4]

Group 1 - The stock price of Tiankang Biological on July 29 closed at 6.50 yuan, down 0.11 yuan, a decrease of 1.66% from the previous trading day [1] - The trading volume on that day was 293,400 hands, with a transaction amount of 190 million yuan, and a turnover rate of 2.15% [1] - Tiankang Biological's main business includes feed, veterinary drugs, pig farming, and slaughter processing within the agricultural and animal husbandry industry chain [1] Group 2 - The company is a significant agricultural and animal husbandry enterprise in the Xinjiang region, involved in multiple fields such as feed production and animal vaccines [1] - According to the company's statement on the investor interaction platform, the cost of pig farming has decreased to 13 yuan per kilogram by early 2025, which is at an industry-leading level [1] - The company maintains cost control stability through optimizing feed formulas, improving production efficiency, and enhancing industry chain collaboration, while actively expanding sales in markets outside Xinjiang [1]